ArticlePharmacology research & perspectives2021

Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice.

Linfen Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.